Skip to content

NTHI NTHI Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Merck & Co. logo
Merck & Co.MRK
Nuvation Bio logo
Nuvation BioNUVB
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×
Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's common stock, shares authorized (in shares)?
NTHI (NTHI) reported common stock, shares authorized (in shares) of $100M in Q1 2026.
How has NTHI's common stock, shares authorized (in shares) changed year-over-year?
NTHI's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $100M to $100M.